Biotechnology Ultra Sector Pro F: (MF: BIPSX)
NAV
$132.37
NAV Day Change
3.24 (2.51%)
Jun 18 06:05 PM ET
General Information As Of 04/30/13
| %Yield | 0.00 |
| %SEC Yield | NA |
| %YTD Return (as of 04/30/13) | 53.27 |
| Objective* | Equity - Sector Health |
| Peer* | HL LG |
Portfolio Statistics
| %Unrealized Gain YTD | 10.95 |
| Net Assets (Mil $) 04/30/2013 | 3.58 |
| %Turnover 04/30/2013 | 6.00 |
Fees
| %Max Sales Load | NA |
| %Min Sales Load | NA |
| %Max Deferred Load | NA |
Expenses
| %Max 12b-1 Fee | 1.00 |
| %Max Management Fee | 0.75 |
| Redemption Fee | NA |
| Expense Ratio | 2.72 |
Allocation
| Large Growth | 49.95 |
| Large Value | 0.00 |
| Small Growth | 0.00 |
| Small Value | 0.00 |
| Foreign Stock | 0.00 |
| Emerging Market | 0.00 |
| Precious Metal | 0.00 |
| Intermediate Bond | 0.00 |
| Foreign Bond | 0.00 |
| High Yield Bond | 0.00 |
Portfolio Information
Composition
| As of 01/31/2013 | %of Net Assets |
| Stock | 55.83 |
| Cash | 0.00 |
| Bonds | 0.00 |
| Preferred | 0.00 |
| Convertibles | 0.00 |
| Foreign Stock | 0.00 |
| Foreign Bonds | 0.00 |
| Hedge | 0.00 |
| Other | 44.17 |
Sector / Country Weightings
| As of 04/30/2013 | % of Portfolio |
|---|---|
| Other | 44.17 |
| Health | 38.24 |
| Services | 10.61 |
| Industrial Cyclical | 5.66 |
| Technology | 1.32 |
Portfolio Holdings
| Top Equity Holdings (As of 01/31/2013) | % of Portfolio | Value (Mil$) |
|---|---|---|
| AMGEN INC | 10.04 | 8.29 |
| GILEAD SCIENCES INC | 9.15 | 7.55 |
| ABBOTT LABORATORIES | 8.89 | 7.34 |
| CELGENE CORP | 6.43 | 5.31 |
| BIOGEN IDEC INC | 5.66 | 4.67 |
| ALEXION PHARMACEUTICALS I | 2.81 | 2.32 |
| REGENERON PHARMACEUTICALS | 2.01 | 1.66 |
| LIFE TECHNOLOGIES CORP | 1.70 | 1.40 |
| VERTEX PHARMACEUTICALS IN | 1.48 | 1.22 |
Contact Information
| Family | ProFunds |
| Addrerss | Po Box 182800 Columbus, OH 43218-2800 |
| Phone | 888 776-5717 |
Zacks Premium Research
Zacks Mutual Fund Rank: 1 - Strong Buy 
| #1 |
Fund Description
The fund was incepted in June 2000 and is managed by ProFund Advisors. The fund seeks daily investment results that correspond to 150%, before fees and expenses, of the performance of the Dow Jones U.S. Biotechnology Index. The fund primarily invests in biotechnology companies. It concentrates investments in a particular industry or group of industries to approximately the same extent the Index is concentrated. The fund may invest in equity caps, collars and floors, swaps, American Depositary Receipts and options on securities and securities indices. Dividends and capital gains are distributed annually.
Stock Holding % of Net Assets
| As Of | 01/31/2013 |
| Total Issues | 26 |
| Avg. P/E | 36.43 |
| Avg. P/Book | 5.82 |
| Avg. EPS Growth | 12.92 |
| Avg. Market Value (Mil $) | 36,473 |
Risk
| 3 Year | 5 Year | 10 Year | |
|---|---|---|---|
| Beta | 1.31 | 0.94 | 1.02 |
| Alpha | 21.32 | 20.49 | 10.53 |
| R Squared | 0.54 | 0.35 | 0.30 |
| Std. Dev. | 26.67 | 30.18 | 27.55 |
| Sharpe | 1.63 | 0.93 | 3.00 |
Shareholder Information
| Manager | Hratch Najarian |
| Since | 10/11 |
| Manager Rating | NA |
| Inception Date | 06/19/2000 |
| Shareholders | NA |
| Dividends Paid | A |
| Minimum Initial Investment | $15,000 |
| Minimum Subsequent Investment | $0 |
| IRA Minimum | $15000 |
| IRA Available | Y | Check Writing | N | Phone Invest | Y |
| Phone Exchange | Y | Phone Redeem | Y | Auto Invest | Y |
| Wire Redeem | Y | Wire Fee | Y | Wire Transfer | Y |
Zacks Commentary for BIPSX
Zacks Blog: Top 5 Best Performing Healthcare Mutual Funds Year to Date
May 29, 2013
Zacks Blog: Top 5 Zacks #1 Ranked Healthcare Mutual Funds
May 16, 2013
Zacks Blog: Top 5 Zacks #1 Ranked Healthcare Mutual Funds
May 03, 2013
Zacks Blog: Top 5 Zacks #1 Ranked Healthcare Mutual Funds
Apr 23, 2013
Zacks Blog: Top 5 Best Performing Healthcare Mutual Funds Year to Date
Apr 09, 2013
